<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04934917</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01142_1pre</org_study_id>
    <nct_id>NCT04934917</nct_id>
  </id_info>
  <brief_title>Brain Imaging of Pain-Related Processing and Structural Properties in Disc Degenerative Disease</brief_title>
  <acronym>POADOSpre</acronym>
  <official_title>Brain Imaging of Pain-Related Processing and Structural Properties in Disc Degenerative Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we apply brain MR imaging techniques at 3 Tesla to assess pain-relevant&#xD;
      processing in patients with disc degenerative disease (DDD) scheduled for back surgery and&#xD;
      age- and gender-matched controls without back pain. Data collection pre-surgery is performed&#xD;
      over two days: On the first day, all participants undergo a battery of questionnaires&#xD;
      relevant for individuals with chronic pain and pain sensitivity testing, including temporal&#xD;
      summation and pressure pain thresholds. On the second day, participants undergo a MRI&#xD;
      protocol, which includes functional MRI (fMRI) and diffusion tensor imaging to assess&#xD;
      microstructural properties and structural connectivity. During fMRI, an experimental pressure&#xD;
      pain paradigm is performed at the calf i.e. a location not connected to patients' chronic&#xD;
      pain condition. Instead, the experimental pain paradigm serves as a condition to test&#xD;
      processing of noxious stimulation unrelated to patients' experienced chronic pain. The&#xD;
      noxious input pressure is individually calibrated to 50 on a 0-100 VAS scale to ensure that&#xD;
      individual pain perceptions, despite different pressure intensities, are comparable across&#xD;
      participants. The sensory stimulation will consist of a low standardized pressure intensity&#xD;
      (150kPa). In an additional fMRI paradigm, participants do not receive stimulation but are&#xD;
      instructed to continuously rate fluctuating spontaneous ongoing back pain (DDD) or perceived&#xD;
      unpleasantness (controls).&#xD;
&#xD;
      This project aims at investigating measures of brain architecture, neural response connected&#xD;
      with evoked pain, connectivity (structural and functional) and pain-relevant psychometrics&#xD;
      and questionnaire data in disc degenerative disease patients scheduled for back surgery.&#xD;
      Specifically, MRI is performed to test whether i) patients display differences in properties&#xD;
      of the mesolimbic circuit compared to healthy individuals and ii) behavioural as well as&#xD;
      clinical characteristics related to the acquired MRI markers. This study is intended to serve&#xD;
      as a baseline in a longitudinal project testing associations with between findings at&#xD;
      baseline and following surgery (fusion/disc implants).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 28, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Functional magnetic resonance imaging (rsfMRI)</measure>
    <time_frame>Baseline</time_frame>
    <description>Analysis of network connectivity during resting state</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional magnetic resonance imaging (BOLD)</measure>
    <time_frame>Baseline</time_frame>
    <description>cerebral pain related activation following evoked pressure pain stimuli</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diffuse Tensor Imaging</measure>
    <time_frame>Baseline</time_frame>
    <description>White matter microstructure (e.g. structural connectivity)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pressure pain thresholds</measure>
    <time_frame>Baseline</time_frame>
    <description>Pressure allometry (mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Temporal summation</measure>
    <time_frame>Baseline</time_frame>
    <description>Pain ratings during repeated pressure stimuli, ratings from 0-100, with 100 being worst pain imaginable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity ratings</measure>
    <time_frame>Baseline</time_frame>
    <description>Visual analogue scale, 0-100 mm, 100 mm, worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Baseline</time_frame>
    <description>0-100, 0=no disability, 100= worst disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibromyalgia criteria-2016 revision (American College of Rheumatology)</measure>
    <time_frame>Baseline</time_frame>
    <description>Calculation of FMness score, 0-31, 0 = no symptoms, 31 = worst symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multidimensional Fatigue Inventory</measure>
    <time_frame>Baseline</time_frame>
    <description>Total fatigue score, range 20-100, 100 = worst fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain catastrophizing scale</measure>
    <time_frame>Baseline</time_frame>
    <description>Total score 0-52, high values more catastrophizing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory</measure>
    <time_frame>Baseline</time_frame>
    <description>Scores 0-63, with 63 highest depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory</measure>
    <time_frame>Baseline</time_frame>
    <description>Scores 20-80 for state and 20-80 for trait anxiety, higher levels indicate more anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQual-5D</measure>
    <time_frame>Baseline</time_frame>
    <description>Scale ranging from -0.224 to 1, with 1 being highest possible health related quality of life</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>Patients with disc degenerative disease (DDD)</arm_group_label>
    <description>Patients suffering from disc degenerative disease, age 30-60 years that are on the waiting list for surgery (fusion/disc implants) at Stockholm Spine Center, Stockholm, Sweden.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls (HC)</arm_group_label>
    <description>Healthy controls matched according to age and sex, no chronic pain conditions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Resonance Imaging</intervention_name>
    <description>Magnetic Resonance Imaging. Pain testing: Temporal summation, Pain thresholds. Assessment of symptoms: Questionnaires. All interventions are made at baseline only (1 time/subject).</description>
    <arm_group_label>Healthy controls (HC)</arm_group_label>
    <arm_group_label>Patients with disc degenerative disease (DDD)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited through clinical collaborators (Stockholm Spine Center, Rygg&#xD;
        Kirurgisk Centrum); HC will be recruited via online advertisement on the institution's&#xD;
        website&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:Inclusion criteria:&#xD;
&#xD;
          -  30-60 year&#xD;
&#xD;
          -  Right-handed&#xD;
&#xD;
          -  DDD patients: Radiologically verified DDD and DDD pain as their main pain complaint&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous spine surgery&#xD;
&#xD;
          -  significant pain problems due to other causes and/or other chronic pain syndromes&#xD;
&#xD;
          -  inflammatory rheumatic diseases&#xD;
&#xD;
          -  neurological/psychiatric disorders&#xD;
&#xD;
          -  severe cardiovascular disease&#xD;
&#xD;
          -  substance abuse&#xD;
&#xD;
          -  BMI&gt;40&#xD;
&#xD;
          -  Contraindication to MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Kosek, Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eva Kosek, Prof, MD</last_name>
    <phone>4685248000000</phone>
    <email>Eva.Kosek@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tony Durkee</last_name>
    <phone>4685248000000</phone>
    <email>compliance@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karolinska Institute</name>
      <address>
        <city>Stockholm</city>
        <zip>171 77</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Kosek, MD., PhD</last_name>
      <phone>46 8 52483230</phone>
      <email>eva.kosek@ki.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karolinska Insitutet</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Kosek</last_name>
    </contact>
    <contact_backup>
      <email>Eva.Kosek@ki.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2021</study_first_posted>
  <last_update_submitted>June 14, 2021</last_update_submitted>
  <last_update_submitted_qc>June 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Eva Kosek</investigator_full_name>
    <investigator_title>Principal Investigator, Professor, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

